MedPath

Comparison of effects of azilsartan and olmesartan in paitents with type 2 diabetes mellitus with hypertension: A crossover trial.

Not Applicable
Conditions
Patients with type 2 diabetes mellitus with hypertension
Registration Number
JPRN-UMIN000012619
Lead Sponsor
Juntendo University Graduate School of Medicine,Department of Metabolism & Endocrinology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
38
Inclusion Criteria

Not provided

Exclusion Criteria

1)Pregnant, lactating, and possibly pregnant women 2)severe liver disease 3)severe kidney disease(s-Cr 2.0mg/dl and mora) 4) Treatment with insurin 5) patients who have allergy to the medicine used in this study 6)Patients attending physician has determined is inappropriate for research participation 7)Patients who do not obtain written consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Office blood pressure
Secondary Outcome Measures
NameTimeMethod
24hour blood pressure,daytime blood pressure,night time blood pressure(ABPM at 16,48weeks),HbA1c, FBG, IRI, urinary microalbumin, glucosylated albumin, hs-CRP, adiponectin, L-FABP, pentraxin3
© Copyright 2025. All Rights Reserved by MedPath